The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients

被引:50
作者
Buchanan, DD [1 ]
Silburn, PA
Chalk, JB
Le Couteur, DG
Mellick, GD
机构
[1] Univ Queensland, Princess Alexandra Hosp, Dept Med, Parkinsons Dis Res Grp, Woolloongabba, Qld 4102, Australia
[2] Princess Alexandra Hosp, Dept Neurol, Woolloongabba, Qld 4102, Australia
[3] Univ Queensland, Ctr Magnet Resonance, St Lucia, Qld 4072, Australia
[4] Concord Hosp, Ctr Educ & Res Aging, Concord, NSW 2139, Australia
关键词
Parkinson's disease; iron; HFE; Cys282Tyr; case-control; single nucleotide polymorphism;
D O I
10.1016/S0304-3940(02)00398-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Iron homeostasis is altered in Parkinson's disease (PD). The HFE protein is an important regulator of cellular iron homeostasis and variations within this gene can result in iron overload and the disorder known as hereditary haemochromatosis. We studied the Cys282Tyr single nucleotide polymorphism as a genetic risk factor for PD in two distinct and separately collected cohorts of Australian PD patients and controls. In the combined cohort comprising 438 PD patients and 485 control subjects, we revealed an odds ratio for possession of the 282Tyr allele of 0.61 (95% confidence interval, Cl = 0.42-0.90, P = 0.011) from univariate chi-squared and 0.59 (95% Cl = 0.39-0.90, P = 0.014) after logistic regression analyses (correcting for potential confounding factors). These results suggest that possession of the 282Tyr allele may offer some protection against the development of PD. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:91 / 94
页数:4
相关论文
共 19 条
  • [1] Genetic association studies of bronchial asthma - a need for Bonferroni correction?
    Boehringer, S
    Epplen, JT
    Krawczak, M
    [J]. HUMAN GENETICS, 2000, 107 (02) : 197 - 197
  • [2] The significance of haemochromatosis gene mutations in the general population: implications for screening
    Burt, MJ
    George, PM
    Upton, JD
    Collett, JA
    Frampton, CMA
    Chapman, TM
    Walmsley, TA
    Chapman, BA
    [J]. GUT, 1998, 43 (06) : 830 - 836
  • [3] Is hemochromatosis a risk factor for Alzheimer's disease?
    Connor, J. R.
    Milward, E. A.
    Moalem, S.
    Sampietro, M.
    Boyer, P.
    Percy, M. E.
    Vergani, C.
    Scott, R. J.
    Chorney, M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2001, 3 (05) : 471 - 477
  • [4] A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
    Feder, JN
    Gnirke, A
    Thomas, W
    Tsuchihashi, Z
    Ruddy, DA
    Basava, A
    Dormishian, F
    Domingo, R
    Ellis, MC
    Fullan, A
    Hinton, LM
    Jones, NL
    Kimmel, BE
    Kronmal, GS
    Lauer, P
    Lee, VK
    Loeb, DB
    Mapa, FA
    McClelland, E
    Meyer, NC
    Mintier, GA
    Moeller, N
    Moore, T
    Morikang, E
    Prass, CE
    Quintana, L
    Starnes, SM
    Schatzman, RC
    Brunke, KJ
    Drayna, DT
    Risch, NJ
    Bacon, BR
    Wolff, RK
    [J]. NATURE GENETICS, 1996, 13 (04) : 399 - 408
  • [5] INCREASED IRON-RELATED MRI CONTRAST IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE
    GORELL, JM
    ORDIDGE, RJ
    BROWN, GG
    DENIAU, JC
    BUDERER, NM
    HELPERN, JA
    [J]. NEUROLOGY, 1995, 45 (06) : 1138 - 1143
  • [6] Hirsch EC, 1998, MOVEMENT DISORD, V13, P39
  • [7] Replication validity of genetic association studies
    Ioannidis, JPA
    Ntzani, EE
    Trikalinos, TA
    Contopoulos-Ioannidis, DG
    [J]. NATURE GENETICS, 2001, 29 (03) : 306 - 309
  • [8] Correcting for multiple testing in genetic association studies: the legend lives on
    Krawczak, M
    Boehringer, S
    Epplen, JT
    [J]. HUMAN GENETICS, 2001, 109 (05) : 566 - 567
  • [9] Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice
    LaVaute, T
    Smith, S
    Cooperman, S
    Iwai, K
    Land, W
    Meyron-Holtz, E
    Drake, SK
    Miller, G
    Abu-Asab, M
    Tsokos, M
    Switzer, R
    Grinberg, A
    Love, P
    Tresser, N
    Rouault, TA
    [J]. NATURE GENETICS, 2001, 27 (02) : 209 - 214
  • [10] Altered systemic iron metabolism in Parkinson's disease
    Logroscino, G
    Marder, K
    Graziano, J
    Freyer, G
    Slavkovich, V
    LoIacono, N
    Cote, L
    Mayeux, R
    [J]. NEUROLOGY, 1997, 49 (03) : 714 - 717